CODOX-M/IVAC regimen

Revision as of 19:21, 11 March 2015 by Aparna Vuppala (talk | contribs) (Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} ==Overview== {{PAGENAME}} refers to a regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-do...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for CODOX-M/IVAC regimen

Articles

Most recent articles on CODOX-M/IVAC regimen

Most cited articles on CODOX-M/IVAC regimen

Review articles on CODOX-M/IVAC regimen

Articles on CODOX-M/IVAC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on CODOX-M/IVAC regimen

Images of CODOX-M/IVAC regimen

Photos of CODOX-M/IVAC regimen

Podcasts & MP3s on CODOX-M/IVAC regimen

Videos on CODOX-M/IVAC regimen

Evidence Based Medicine

Cochrane Collaboration on CODOX-M/IVAC regimen

Bandolier on CODOX-M/IVAC regimen

TRIP on CODOX-M/IVAC regimen

Clinical Trials

Ongoing Trials on CODOX-M/IVAC regimen at Clinical Trials.gov

Trial results on CODOX-M/IVAC regimen

Clinical Trials on CODOX-M/IVAC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on CODOX-M/IVAC regimen

NICE Guidance on CODOX-M/IVAC regimen

NHS PRODIGY Guidance

FDA on CODOX-M/IVAC regimen

CDC on CODOX-M/IVAC regimen

Books

Books on CODOX-M/IVAC regimen

News

CODOX-M/IVAC regimen in the news

Be alerted to news on CODOX-M/IVAC regimen

News trends on CODOX-M/IVAC regimen

Commentary

Blogs on CODOX-M/IVAC regimen

Definitions

Definitions of CODOX-M/IVAC regimen

Patient Resources / Community

Patient resources on CODOX-M/IVAC regimen

Discussion groups on CODOX-M/IVAC regimen

Patient Handouts on CODOX-M/IVAC regimen

Directions to Hospitals Treating CODOX-M/IVAC regimen

Risk calculators and risk factors for CODOX-M/IVAC regimen

Healthcare Provider Resources

Symptoms of CODOX-M/IVAC regimen

Causes & Risk Factors for CODOX-M/IVAC regimen

Diagnostic studies for CODOX-M/IVAC regimen

Treatment of CODOX-M/IVAC regimen

Continuing Medical Education (CME)

CME Programs on CODOX-M/IVAC regimen

International

CODOX-M/IVAC regimen en Espanol

CODOX-M/IVAC regimen en Francais

Business

CODOX-M/IVAC regimen in the Marketplace

Patents on CODOX-M/IVAC regimen

Experimental / Informatics

List of terms related to CODOX-M/IVAC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:

Overview

CODOX-M/IVAC regimen refers to a regimen consisting of cyclophosphamide, vincristine, doxorubicin and high-dose methotrexate (CODOX-M) alternating with ifosfamide, etoposide and high-dose cytarabine (IVAC), used as a treatment for aggressive forms of non-Hodgkin's lymphoma; also used as primary treatment for AIDS-related and high-risk Burkitt's lymphoma. Intrathecal cytarabine and methotrexate are included in this regimen as either prophylaxis or treatment for central nervous system (CNS) involvement.

Regimen

CCyclophosphamide VVincristine DOXDoxorubicin MMethotrexate

IIfosfamide

Eetoposide

CCytarabine


Indications

References